Future for ovarian cancer screening: novel markers from emerging technologies of transcriptional profiling and proteomics
- PMID: 11584052
- DOI: 10.1093/jnci/93.19.1437
Future for ovarian cancer screening: novel markers from emerging technologies of transcriptional profiling and proteomics
Comment on
-
Prostasin, a potential serum marker for ovarian cancer: identification through microarray technology.J Natl Cancer Inst. 2001 Oct 3;93(19):1458-64. doi: 10.1093/jnci/93.19.1458. J Natl Cancer Inst. 2001. PMID: 11584061
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
